CardioLogic Innovations has developed a patented platform technology that enables precise monitoring of the fluid level in each lung in order to prevent the major cause of acute heart failure hospitalizations. The CardioLogic product line includes noninvasive devices for inpatient, outpatient, and home use, as well as an integrative solution for enhancing the current implantable cardiac resynchronization therapy and implantable cardioverter defibrillator devices.